Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5445_Библиотеки_им_академика_М_И_Перельмана.pdf
297
Review of the
Document
Inspection of locally
produced or imported product
samples, manufacturing
facilities, and the
marketplace.
Testing of the
Product
Reporng
Analysis and
Evaluation of
Data
Making
Decisions and
Enforcement
Fig. 13.1 Various stages in quality control and quality assurance of pharmaceutical products
standards adequate for their intended use and as required by marketing authoriza-
tion. Figure13.2 shows an overview of the various phases in the pharmaceutical
quality assurance framework. A complete quality assurance program should ensure
the following:
• Suppliers who meet acceptable quality criteria are selected.
• Selected medications are safe as well as effective for the use it is intended, avail-
able in suitable doses, with prolong shelf life.
• Packaging satises contractual and use criteria.
• Pharmaceuticals received from commercial vendors and donations fulll speci-
ed quality criteria upon delivery.
• Product quality must be maintained during storage and transportation.
• Product quality complaints from prescribers, dispensers, and customers are
appropriately documented and addressed.
• Repackaging and dispensing processes ensure quality.
• Defective products are removed via product recall methods.
13.6 Intellectual Property Considerations forInulin-Based
Pharmaceutical Products
The word “intellectual property” denotes to the state’s undivided rights in creations
of human mind, innovative inventions, literary and ingenious works, and commer-
cial designs. It is categorized into two separate categories, i.e., industrial property
(IP) rights, which comprises of patents, industrial designs, trade secrets, geographi-
cal indications, trademarks, copyright, and associated rights for artistic works and
literary. Inulin-based pharmaceutical products to be marketed need to give consid-
eration in preserving the intellectual property rights (Anjuomo etal. 2021).
13 Regulatory Aspects ofInulin-Based Pharmaceutical Products
298
Fig. 13.2 Quality assurance framework
Intellectual property rights are crucial in pharmaceutical companies. The use of
the intellectual property system in pharmaceutical companies is highly inuenced
by the company’s business strategy, size, innovative ability, resources, competitive
environment, and area of prociency. Innovation-driven as well as research-based
companies that try to produce novel pharmaceuticals, modify or change existing
treatments, or develop a completely new pharmaceutical product/medical devices or
processes depend mainly on the patent system to recuperate R&D costs.
Other types of trade secrets include research and development expertise, soft-
ware algorithms, innovations, formulations, designs, materials, devices, as well as
other approaches. The trademark system is crucial for businesses that sell products
under some brand names. Most SMEs in the pharmaceutical industry are less con-
cerned with copyrights, industrial designs, preservation of plant varieties, and
related rights, though this may differ subjected on the company’s range of products
and different strategies.
P. Jindal et al.
299
A patent is a state-granted exclusive right to a new invention that requires an
innovative step and is appropriate for industrial use. It gives the inventor the only
power to restrict others from making, utilizing, offering for selling the patented
invention without prior inventor’s consent. A patent is an important commercial
instrument that helps companies gain market exclusivity for any novel product or
process, establish a robust market position, or increase prots via licensing. Patents
are granted by both national as well as different regional patent ofces. It is effective
for a limited duration, which is usually around 20years from the submission date of
new patent application, considering that renewal fees are paid off to retain the patent
in force (Savale and Savale 2016).
A trademark is an identifying mark that distinguishes one company’s goods or
services from those of others. Trademarks are distinctive words, characters, num-
bers, drawings, images, forms, and other combinations that differentiate the origin
of goods as well as services. The advertising phrases are recognized as trademarks
in some countries and can be recorded with national trademark organizations. In
addition to logo and brand name protection, pharmaceutical companies in some
countries depend on trademark protection of pharmaceutical items as wll as product
packaging (Ramello 2006).
13.7 Challenges andOpportunities intheRegulatory
Approval ofInulin-Based Pharmaceutical Products
The special qualities of inulin, including its molecular exibility, ability to stabilize
proteins, and simplicity in chemical modication, make it a desirable option for
drug delivery systems. Because of these characteristics, inulin may stabilize pro-
teins and self-assembled structures, which makes it benecial for use in medicinal
delivery systems and vaccinations. However, challenges include ensuring consistent
quality, safety, and efcacy across different batches, as well as navigating complex
regulatory landscapes that vary by region (Ghali etal. 2024).
Distinctive properties of inulin like molecular exibility, ease of modication,
and ability to stability proteins make them an ideal candidate for pharmaceutical
drug delivery systems. However, there are numerous challenges and opportunities
when considering the regulatory approval from the different bodies, ensuring safety,
efcacy, and quality of inulin and the pharmaceutical products based on it. The dif-
ferent challenges in regularity approval of inulin-based products include complex
regulatory requirements based on the regions (Akram etal. 2024). The approval
process of the inulin-based pharmaceutical products through regulatory agencies is
a time-consuming process which may sometimes cause a unnecessary delay leading
to increase in the overall cost. The regulatory approval through different agencies
also requires extensive preclinical and clinical data for the inulin-based pharmaceu-
tical products. This sometimes pose a challenge as it requires substantial investment
and funding which might cause a delay in product launch in the market. The com-
plexities involve in the manufacturing of the inulin-based products may cause the
delay in the approval from the regulatory agencies. Thus, appropriate good
13 Regulatory Aspects ofInulin-Based Pharmaceutical Products
300
manufacturing practices must be employed to overcome these challenges. Even
after getting approval from the regulatory bodies, another major challenge is public
acceptance of the new drug delivery systems based on inulin. Thus, a comprehen-
sive data about the safety and benets on inulin-based pharmaceutical products can
provide.
Inulin-based products can provide a variety of opportunities, including the devel-
opment of targeted medication delivery systems for genetic materials and cancer
therapies. Thus, regulatory approval is required to make sure that the inulin-based
pharmaceutical products meet their safety standards and can be used effectively for
their intended use. The inulin can be appropriately modied to improve drug deliv-
ery properties, but simultaneously it needs proper validation and documentation to
satisfy and get approval from regulatory bodies.
13.8 Conclusion andFuture Directions
Inulin, a naturally occurring fructan-type plant polysaccharide, is known for its
exible structure, stabilizing capabilities, and ability to target specic organs,
making it an ideal drug delivery carrier. Regulatory approval of inulin-based
pharmaceuticals involves extensive preclinical and clinical studies to ensure
safety and efcacy, with varying standards across regions. Following good
manufacturing practices (GMP), QA, and QC is critical for ensuring product
uniformity and preventing contamination. Intellectual property protection,
particularly through patents, is vital for safeguarding innovations and ensuring
market exclusivity. Various regulatory bodies worldwide, such as the FDA, EMA,
and CDSCO, oversee the approval and quality of these pharmaceuticals, ensuring
they meet strict standards for public health.
References
Anjuomo F, Abdella S, Youssef SH, Song Y, Garg S (2021) Pharmaceuticals 14:855
Agarwal C, Satya P (2017) Central Drugs Standard Control Organization, New Delhi
Ahmed W, Rashid S (2019) Crit Rev Food Sci Nutr 59:1–13
Akram W, Pandey V, Sharma R, Joshi R, Mishra N, Garud N, Haider T (2024) Int J Biol Macromol
259:129131
Apolinário AC, de Lima Damasceno BPG, de Macêdo Beltrão NE, Pessoa A, Converti A, da Silva
JA (2014) Carbohydr Polym 101:368–378
Aziza F (2021) Majalah Farmaseutik 17:243
Canfora EE, Hermes GDA, Müller M, Bastings J, Vaughan EE, van Den Berg MA, Holst JJ,
Venema K, Zoetendal EG, Blaak EE (2022) Gut Microbes 14:2009297
Carboni AD, Salinas MV, Puppo MC (2022) Handbook of food bioactive ingredients. Springer
International Publishing, Cham, pp1–30
Clark MJ, Slavin JL (2013) Journal of the American College of Nutrition 32(3):200–11
D.S.P, Agarwal C (2017) Central Drugs Standard Control Organization
Fernando F (2020) Inulin and S. salivarius reduce halitosis
Geigert J (2002) Quality assurance and quality control for biopharmaceutical products.
Development and Manufacture of Protein Pharmaceuticals 361–404
P. Jindal et al.
301
Ghali ENHK, Pranav, Chauhan SC, Yallapu MM (2024) Int J Biol Macromol 259:129216
Ghante M, Dargude S, Patil A, Bhusari V (2024) Modern aspects of pharmaceutical quality assur-
ance. Springer Nature Singapore, Singapore, pp1–7
Hiel S, Bindels LB, Pachikian BD, Kalala G, Broers V, Zamariola G, Chang BP, Kambashi
B, Rodriguez J, Cani PD, Neyrinck AM (2019) The American journal of clinical nutrition
109(6):1683–95.
Holscher HD, Bauer LL, Gourineni V, Pelkman CL, Fahey GC, Swanson KS (2015) J Nutr
145:2025–2032
Jackson PPJ, Wijeyesekera A, Theis S, Van Harsselaar J, Rastall RA (2023). Effects of food
matrix on the prebiotic efcacy of inulintype fructans: a randomised trial. Benef Microbes
14(4):317–334
Jessica B (2018) Treating IBD with inulin, Philadelphia, PA
Kalyani Nair K, Kharb S, Thompkinson DK (2010) Food Rev Intl 26:189–203
Leyrolle Q, Cserjesi R, Mulders MDGH, Zamariola G, Hiel S, Gianfrancesco MA, Rodriguez J,
Portheault D, Amadieu C, Leclercq S, Bindels LB, Neyrinck AM, Cani PD, Karkkainen O,
Hanhineva K, Lanthier N, Trefois P, Paquot N, Cnop M, Thissen J-P, Klein O, Luminet O,
Delzenne NM (2021) Clin Nutr 40:2035–2044
Lile DJ (2023) Translational surgery. Elsevier, pp501–507
Marchildon GP (2013) Marchildon GP, Allin S, Merkur S. Health Systems in Transition Third
Edition. University of Toronto Press; 2021 Apr 21
Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ (2015) Carbohydr Polym
130:405–419
Mudannayake DC, Jayasena DD, Wimalasiri KMS, Ranadheera CS, Ajlouni S (2022) Int J Food
Sci Technol 57:5764–5780
Petry N, Egli I, Chassard C, Lacroix C, Hurrell R (2012) Am J Clin Nutr 96:325–331
Pignatti F, Gravanis I, Herold R, Vamvakas S, Jonsson B, Marty M (2011) Clin Cancer Res
17:5220–5225
Raj DS, Sohn MB, Charytan DM, Himmelfarb J, Ikizler TA, Mehrotra R, Ramezani A,
Regunathan-Shenk R, Hsu JY, Landis JR, Li H, Kimmel PL, Kliger AS, Dember LM (2021)
Kidney 360(2):445–455
Ramello GB (2006) J Econ Surv 20:547–565
Redondo-Cuenca A, Herrera-Vázquez SE, Condezo-Hoyos L, Gómez-Ordóñez E, Rupérez P
(2021) Ind Crop Prod 170:113726
Robin S (2024) Effect of rate of delivery on colonic fermentation of inulin (EON), clinical
Trials.gov, Bethesda, MD
Rubel IA, Iraporda C, Manrique GD, Genovese DB, Abraham AG (2021) Bioact Carbohydr Diet
Fibre 26:100281
Savale SK, Savale VK (2016) World J Pharm Pharm Sci 5:2559–2592
Shinya M (2019) JMA J 2:1–10
Shoaib M, Shehzad A, Omar M, Rakha A, Raza H, Sharif HR, Shakeel A, Ansari A, Niazi S (2016)
Carbohydr Polym 147:444–454
Sohn MB, Gao B, Kendrick C, Srivastava A, Isakova T, Gassman JJ, Fried LF, Wolf M, Cheung
AK, Raphael KL, Vinales PC, Middleton JP, Pabalan A, Raj DS (2024) Pilot studies in CKD
consortium. Kidney Int Rep 9:671–685
Tawck MM, Xie H, Zhao C, Shao P, Farag MA (2022) Int J Biol Macromol 208:948–961
Thomas R, Aldous JW, Forsyth R, Chater AM, Williams M (2021) Infectious Diseases Diagnosis
& Treatment, Gavin Publishers, USA
van den Haak Merel A, Kiltie AE (2023). Exploring mechanism of action of dietary bre on the gut
microbiota and metabolites (MERLIN). https://clinicaltrials.gov/study/NCT05906589
Veronica O (2024) Inulin supplementation in patients with type 1 diabetes, clinical Trials.gov,
Bethesda, MD NCT057959723099
13 Regulatory Aspects ofInulin-Based Pharmaceutical Products
303
14
Therapeutic Role ofInulin inDisease
Management
AnchalaGuglani, SwatiShukla, andRaviTripathi
Abstract
Inulin is a naturally occurring dietary ber belonging to the group of carbohy-
drates known as fructans. It is widely used in food processing as a prebiotic, ber
supplement, and fat substitute due to its unique functional properties. As a ber
supplement, it enhances gut health by serving as a substrate for benecial gut
bacteria, which supports the immune system, improves metabolic health, and
may contribute to the management of diabetes and cardiovascular diseases.
Additionally, inulin has also demonstrated tremendous potential in inuencing
cognitive health through modulation of the gut-brain axis and its signicant role
in mineral absorption and bone health. This comprehensive analysis positions
inulin as a promising dietary ber with multifaceted therapeutic potential, from
digestive health to chronic disease management.
Keywords
Inulin · Dietary ber · Prebiotic · Therapeutic effect · Disease management
A. Guglani (*)
Department of Biology, Georgia State University, Atlanta, GA, USA
e-mail: aguglani@gsu.edu
S. Shukla
Department of Pharmacy, Teerthanker Mahaveer University, Moradabad, Uttar Pradesh, India
R. Tripathi
Department of Biomedical Engineering, Emory University, Atlanta, GA, USA
304
14.1 Introduction
Dietary bers play a pivotal role in maintaining human health, offering a wide range
of physiological benets (Barber etal. 2020). Among these bers, inulin is increas-
ingly recognized for its signicant health benets (Sheng etal. 2023; Kaur etal.
2021; Teferra 2021). This naturally occurring dietary ber, prevalent in a variety of
plants such as chicory root, garlic, onions, and asparagus, has transcended its tradi-
tional boundaries to reveal its potential for disease management and health promo-
tion (Kaur etal. 2021). Inulin primarily comprises fructose as monomeric units with
a glucose endpoint, distinguishing it as a vital storage carbohydrate in an extensive
variety of plants. Inulin belongs to the fructan group of carbohydrates, composed
mainly of β-D-fructosyl subgroups linked by (2→1) glycosidic bonds, with the
molecule usually terminating in a (1↔2) bonded α-D-glucosyl group (Shelke etal.
2022; Mensink etal. 2015). Its unique structure is dened by fructose units con-
nected by β (2→1) linkages, ending in a glucose residue, imparting inulin with
unique solubility characteristics (Mensink etal. 2015). The degree of polymeriza-
tion (DP), which varies from 2 to 60units depending on the plant species, age, and
extraction techniques, inuences its fermentability and physiological impact, espe-
cially in the gastrointestinal tract (Chen etal. 2024; Guimarães etal. 2020). The
physicochemical and functional properties of inulin are intricately linked to its DP
as well as the presence of branching within its structure. The solubility of inulin,
which decreases with an increase in DP, is essential for its role in food applications,
as it remains stable under severe processing conditions due to its resilience to deg-
radation at relevant pH ranges and high temperature (Teferra 2021; Li etal. 2020;
Ito etal. 2011). Moreover, inulin’s crystalline structure can exhibit different mor-
phologies—obloid and needle-like—depending on the cooling temperature of inu-
lin from solutions, showcasing its adaptability in various food systems (Teferra
2021; Mensink etal. 2015).
During the digestive process, inulin bypasses digestion in the upper gastroin-
testinal tract and arrives intact in the large intestine, where it serves as a substrate
for benecial gut bacteria (Healey etal. 2018). The fermentation process pro-
duces short-chain fatty acids (SCFAs) which serve as energy sources for colono-
cytes, and play an important role in lipid metabolism and glucose regulation
(Birkeland etal. 2020; Valcheva etal. 2019). Recent studies highlight the poten-
tial of inulin in glycemic control by modulating insulin sensitivity and glucose
homeostasis, thus offering a promising adjunct therapy for diabetes management
(Wang etal. 2019; Liu etal. 2017). Figure14.1 shows some of the major health
benets of inulin. Moreover, a meta-analysis of randomized controlled trials has
revealed its benecial effects on fasting blood glucose and hemoglobin A1c
(HbA1c) levels in type 2 diabetes patients, although outcomes vary based on inu-
lin type and dosage, indicating the need for personalized dietary recommenda-
tions (Wang etal. 2019; Liu etal. 2017). Incorporating inulin into the diet through
natural food sources, such as onions, garlic, chicory root, and supplements, is
generally safe, though excessive intake can lead to gastrointestinal discomfort in
A. Guglani et al.
305
Fig. 14.1 Some of the major benets of inulin in digestive and cardiovascular health, weight
management, and calcium absorption. Image created by using ChatGPT
some individuals, emphasizing the importance of moderation (Wang 2009;
Bonnema etal. 2010; Ripoll etal. 2010).
As research continues to unravel the complex interactions between diet, micro-
biota, and health, the role of inulin in the gut-brain axis emerges as a fascinating
area of study (Ji etal. 2024; Corrêa etal. 2023). Its potential in enhancing gut bar-
rier function and modulating the immune response opens new avenues for therapeu-
tic applications, from digestive wellness to cognitive function. The prebiotic nature
of inulin, feeding of the benecial gut microbiota, forms the cornerstone of its
health benets by inuencing a wide spectrum of health conditions and highlighting
its signicance as a dietary ber.
In conclusion, the multifaceted role of inulin in health promotion and disease
management highlights its signicance as a dietary ber. By fostering a healthy gut
microbiome, inuencing metabolic processes, and offering therapeutic benets
across various conditions, inulin represents a promising area of nutritional research
and application (Ji etal. 2024; Corrêa etal. 2023). As we peer into the future, the
research areas and potential therapeutic applications of inulin continue to evolve.
Promising new insights of role of inulin in the management of chronic diseases and
mental health, demonstrate the therapeutic potential of inulin. This chapter aims to
14 Therapeutic Role ofInulin inDisease Management
306
explore the therapeutic potential of inulin, highlighting its health benets, the key
properties that contribute to these effects, and its promising application in managing
and preventing diseases.
14.2 Key Properties Contributing toTherapeutic Effects
The therapeutic effects of inulin are attributed to its unique properties, including its
prebiotic nature (Sect. 14.2.1), solubility, fermentability (Sect. 14.2.2), and chemi-
cal nature (Sect. 14.2.3) (Teferra 2021; Song etal. 2024; Mohammadi etal. 2023;
Weitkunat etal. 2017). As a soluble ber, inulin dissolves in the gut to form a gel-
like substance that slows digestion and enhances nutrient absorption. Its fermenta-
tion by gut microbiota produces SCFAs, which have been linked to numerous health
benets, including anti-inammatory effects and protection against colon cancer
(Mohammadi etal. 2023; Song etal. 2020a). The prebiotic nature of inulin speci-
cally promotes the growth of benecial bacteria, such as Bidobacteria and
Lactobacilli, which are crucial for maintaining gut health and immune function.
These facets collectively contribute to inulin’s multifaceted health benets, making
it a subject of growing interest in nutritional science and therapeutic applications
(Weitkunat etal. 2017; van der Beek etal. 2018).
14.2.1 Prebiotic Nature
The foundation of health benets of the inulin is its prebiotic nature (Yin etal.
2023). International Scientic Association (ISAPP) dened prebiotics as a substrate
that is selectively utilized by host microorganisms, conferring a health benet
(Gibson etal. 2017). Prebiotics are dened by three key characteristics (Yin etal.
2023): (i) indigestibility, meaning they resist gastric acidity, enzymes, and absorp-
tion; (ii) the ability to be fermented by health-promoting intestinal microora; and
(iii) the selective stimulation of growth and activity in bacterial groups that contrib-
ute to the improved health and well-being of humans or animals. Inulin not only
fosters the growth of benecial gut bacteria but also enhances the immune response
(van der Beek etal. 2018). This biopolymer belongs to the fructans family, serving
as a substrate for the benecial bacteria in the digestive system, such as
Bidobacterium, known for producing vitamins, SCFAs, and antibacterial com-
pounds (Yin etal. 2023). The presence of inulin in the diet has been linked to an
increase in health-promoting bacteria, thereby promoting gut health and offering
protection against various diseases (van der Beek et al. 2018; Yin et al. 2023;
Fernandes etal. 2017). In Sect. 14.5, a detailed analysis of prebiotic nature of inulin
is provided.
A. Guglani et al.